tetraphenylphosphonium has been researched along with levofloxacin in 1 studies
Studies (tetraphenylphosphonium) | Trials (tetraphenylphosphonium) | Recent Studies (post-2010) (tetraphenylphosphonium) | Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) |
---|---|---|---|---|---|
438 | 0 | 39 | 4,346 | 581 | 2,209 |
Protein | Taxonomy | tetraphenylphosphonium (IC50) | levofloxacin (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Betacoronavirus England 1 | 7.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alenazy, R; Gu, X; Ma, S; Polyak, SW; Sykes, MJ; Venter, H; Wang, Y; Zhang, N; Zhang, P | 1 |
1 other study(ies) available for tetraphenylphosphonium and levofloxacin
Article | Year |
---|---|
Design and structural optimization of novel 2H-benzo[h]chromene derivatives that target AcrB and reverse bacterial multidrug resistance.
Topics: Anti-Bacterial Agents; Benzopyrans; Cell Membrane Permeability; Drug Design; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Hydrogen Bonding; Microbial Sensitivity Tests; Models, Molecular; Multidrug Resistance-Associated Proteins; Protein Binding; Structure-Activity Relationship | 2021 |